Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is -62.37% vs 38.54% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is 106.52% vs -8.61% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is -32.55% vs 131.30% in Mar 2024
Compare Balance Sheet Results of Vilin Bio Med
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
13.95
11.70
2.25
19.23%
Share Warrants & Outstandings
Total Reserve
9.11
17.27
-8.16
-47.25%
Shareholder's Funds
23.06
29.72
-6.66
-22.41%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
0.16
-0.16
-100.00%
Secured Loans
0.00
0.16
-0.16
-100.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
0.09
1.16
-1.07
-92.24%
Other Long Term Liabilities
0.00
0.25
-0.25
-100.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
0.09
1.57
-1.48
-94.27%
Current Liabilities
Trade Payables
1.39
11.67
-10.28
-88.09%
Other Current Liabilities
0.61
2.51
-1.90
-75.70%
Short Term Borrowings
2.57
11.97
-9.40
-78.53%
Short Term Provisions
0.00
0.00
0.00
0.00%
Total Current Liabilities
4.57
26.15
-21.58
-82.52%
Total Liabilities
27.73
57.44
-29.71
-51.72%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
9.39
18.37
-8.98
-48.88%
Less: Accumulated Depreciation
8.11
8.24
-0.13
-1.58%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
1.28
10.13
-8.85
-87.36%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
1.57
2.22
-0.65
-29.28%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
0.27
-0.27
-100.00%
Long Term Loans & Advances
5.06
0.00
5.06
0.00%
Other Non Current Assets
7.26
1.41
5.85
414.89%
Total Non-Current Assets
15.17
14.03
1.14
8.13%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
4.41
7.49
-3.08
-41.12%
Sundry Debtors
6.31
24.75
-18.44
-74.51%
Cash and Bank
0.06
3.27
-3.21
-98.17%
Other Current Assets
1.08
0.00
1.08
0.00%
Short Term Loans and Advances
0.70
7.91
-7.21
-91.15%
Total Current Assets
12.56
43.42
-30.86
-71.07%
Net Current Assets (Including Current Investments)
7.99
17.27
-9.28
-53.73%
Total Current Assets Excluding Current Investments
12.56
43.42
-30.86
-71.07%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
27.73
57.44
-29.71
-51.72%
Contingent Liabilities
0.00
0.09
-0.09
-100.00%
Total Debt
2.57
12.13
-9.56
-78.81%
Book Value per share (adjusted)
16.53
24.76
-8.23
-33.24%
Annual - Borrowings
Borrowings 2.57 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -62.37% vs 38.54% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 2.85 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 106.52% vs -8.61% in Mar 2024
Annual - Investments
No Investments in the last few periods
No Investments in the last few periods;
Annual - Current Assets
Current Assets 12.56 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -32.55% vs 131.30% in Mar 2024






